PluroGen Therapeutics, Inc.
On track to be the 1st topical antibiotic for Diabetic Ulcers approved by FDA, PluroGen specializes in simple solutions for burns and wounds
PluroGel products offer simple solutions for complex wounds through exclusive properties that are effective in all stages of wound healing. PluroGel Products create and maintain the ideal wound environment for the patient to do the healing. We have 3 products: PluroGel SINGLE (PSSD) currently sold in Europe and successfully treating chronic wounds, PluroGel PLAIN, for non-infected wounds, and PluroGel DOUBLE (PN) in Phase IIa FDA trials.